Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

4502

Pozycja w akcjach #378
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Cena akcji
$40.26
Kapitalizacja rynkowa
$64.06B
Zmiana (1 dzień)
0.71%
Zmiana (1 rok)
42.44%
Kraj
JP
Handel Takeda Pharmaceutical Company Limited (4502)

Kategoria

Healthcare
Historia podziałów akcji dla Takeda Pharmaceutical Company Limited (4502)
Akcje Takeda Pharmaceutical Company Limited (symbol: 4502) przeszły łącznie 0 podziałów.
Najnowszy podział miał miejsce Oct 22, 2026.
Jedna akcja 4502 kupiona przed Oct 22, 2026 odpowiada dziś 0 akcjom 4502.
Lista podziałów akcji
Rok Podział Mnożnik Skumulowany mnożnik
Za mało danych dla podanych dat.
Podziały akcji dla podobnych firm lub konkurencji